T2 Biosystems, Inc. (NAS: TTOO) Stock Analysis & Fundamentals | ScreenerHero

Create free account

TTOOT2 Biosystems, Inc.

NAS · US · Healthcare · Diagnostics & Research · investors.t2biosystems.com

0.0007USD0.00%Mkt Cap: 19631 $P/E: —2d ago

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel.…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

Indicators:|

Key Statistics

Company

Market Cap19.63K $

Enterprise Value16.88M $

Revenue (TTM)7.68M $

Gross Profit-8.17M $

Net Income (TTM)-50.08M $

Revenue/Share0.7290 USD

Last Price0.0007 USD

Fiscal Year EndDec 2023

MR QuarterSep 2024

Employees113

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS89853L2034

Valuation

P/E (Trailing)—

P/E (Forward)-0.00

PEG—

EV/EBITDA-0.41

EV/Revenue2.20

P/S0.00

P/B-0.00

EPS (TTM)-0.03

EPS (Forward)-1.19

52W Range

0.00011% of range0.1200

52W High0.1200 USD

52W Low0.0001 USD

Profitability

Gross Margin-113.58%

Oper. Margin-511.89%

EBITDA Margin0.00%

Profit Margin-696.19%

ROE178.62%

ROA-143.91%

Growth

Revenue Growth34.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-48.14M $

CapEx (TTM)192.00K $

FCF Margin-343.45%

FCF Yield-134312.44%

Net Debt16.86M $

Net Debt/EBITDA-0.41

Balance Sheet

Debt/Equity-1.77

Current Ratio0.40

Quick Ratio0.17

Book Value/Sh-0.6240 USD

Cash/Share0.0990 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:100

Split DateOct 13, 2023

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.28.05M

Float11.90M

Insiders5.38%

Institutions0.00%

Short Interest

Short Ratio0.7d

Short % Float4.87%

Short % Out.3.02%

Shares Short846.14K

Short (prev mo.)942.49K

Technical

SMA 500.0010 (-31.0%)

SMA 2000.0051 (-86.3%)

Beta7.76

S&P 52W Chg20.25%

Avg Vol (30d)7.78K

Avg Vol (10d)10.96K

Technical Indicators

RSI (14)48.4

MACD-0.0001

MACD Signal-0.0001

MACD Hist.-0.0000

BB Upper0.0024 USD

BB Middle0.0008 USD

BB Lower-0.0007 USD

BB Width365.91%

ATR (14)0.0013 USD

Vol Ratio (20d)0.00x